9MW0311

· Mabwell (Shanghai) Bioscience Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for 9MW0311, covering 2025-02-03 to 2026-08-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study on Efficacy, Safety and Immunogenicity of 9MW0311 in Postmenopausal Women With Osteoporosis [Phase 3]